Fatal interstitial pneumonitis in a patient treated with pegylated interferon alpha-2b and ribavirin for hepatitis C infection Source: Eur Respir J 2003; 22: Suppl. 45, 44s Year: 2003
Successful hepatitis B treatment with lamivudine and interferon-alpha in a patient with cystic fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 617s Year: 2004
Sarcoidosis associated with interferon-α therapy for chronic hepatitis C Source: Eur Respir J 2006; 28: Suppl. 50, 541s Year: 2006
The role of hepatitis C virus infections in idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 333s Year: 2005
Interstitial lung involvement in patients with chronic HCV hepatitis Source: Eur Respir J 2006; 28: Suppl. 50, 744s Year: 2006
Prevention of drug-induced liver injury in patients with pulmonary tuberculosis and chronic hepatitis C Source: International Congress 2019 – Clinical problems from non-malignant pleural disease to hypoventilation Year: 2019
Evaluation of efficacy of interferon inducer in treatment of the recurrent acute respiratory viral infections in children Source: Annual Congress 2012 - Fungal, viral and other infections Year: 2012
The treatment of cough with interferon in adult patients with stable chronic bronchitis Source: Eur Respir J 2003; 22: Suppl. 45, 426s Year: 2003
Evolution of previous sarcoidosis under type 1 interferons given for severe associated disease Source: Eur Respir J 2005; 25: 570-573 Year: 2005
The frequency of respiratory infections in patients with chronic hepatitis C treated with pegylated-Interferon Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015
Clinical-evolutive aspects of pulmonary tuberculosis at patients with chronic hepatitis Source: Annual Congress 2007 - Tuberculosis Year: 2007
The prevalence rate of chronic hepatitis B and C among pulmonary TB patients Source: Annual Congress 2008 - Tuberculosis in immigrants, disadvantaged populations, elderly, HIV-seropositives and in other risk groups Year: 2008
Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosis Source: Eur Respir J 2006; 28: 496-504 Year: 2006
Non-specific interstitial pneumonia of the pediatric age and recombinant interferon gamma-1b Source: Eur Respir J 2004; 24: Suppl. 48, 717s Year: 2004
Fulminant hepatitis during antituberculosis chemotherapy: five case reports Source: Eur Respir J 2005; 26: Suppl. 49, 645s Year: 2005
Interferon-γ therapy in two patients with progressive chronic pulmonary aspergillosis Source: Eur Respir J 2006; 27: 1307-1310 Year: 2006
Efficacy of short-term prednisolone treatment in patients with chronic eosinophilic pneumonia Source: Eur Respir J 2015; 45: 1624-1631 Year: 2015
Interferon inducer in treatment of acute respiratory viral infections in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014
Severe hepatitis associated with sitaxentan and response to glucocorticoid therapy Source: Eur Respir J 2009; 33: 1518-1519 Year: 2009
Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia Source: Eur Respir J 2005; 25: 528-533 Year: 2005